Condition: Metastatic Gastrointestinal Stromal Tumor (GIST) · C-KIT Mutation · Advanced Gastrointestinal Stromal Tumor (GIST) · Sponsor: Centre Leon Berard
This is a 2 arms study concerning patients under imatinib treatment for at least 10 years of treatment with locally advanced/metastatic GIST. In the first arm, patients will discontinue Imatinib treatment. This arm will allow to determine if the re-introduction of Imatinib at relapse is still an efficient treatment for the control of disease. In the second arm, patients will continue Imatinib treatment, allowing to determine if the continuation of this treatment is efficient for disease control, by the rate of non-progression disease.
This description comes directly from the study's public registry record.
Jean-Yves BLAY, Pr · +33 4 78 78 27 57 · jean-yves.blay@lyon.unicancer.fr
Always discuss trial participation with your own doctor first.
| CHU Besançon | Besançon, France | Recruiting |
| Institut Bergonié | Bordeaux, France | Recruiting |
| CHU Dupuytren | Limoges, France | Recruiting |
| Centre Léon Bérard | Lyon, France | Recruiting |
| Institut Paoli Calmettes | Marseille, France | Not Yet Recruiting |
| Institut Curie | Paris, France | Not Yet Recruiting |
| CHU de Reims | Reims, France | Recruiting |
| Centre Eugène Marquis | Rennes, France | Not Yet Recruiting |
| Institut de Cancérologie de l'Ouest - Site Réné Gauducheau | Saint-Herblain, France | Not Yet Recruiting |
| Institut de Cancérologie Lucien NEUWIRTH | Saint-Paul-en-Jarez, France | Not Yet Recruiting |
| Institut Claudius Regaud | Toulouse, France | Not Yet Recruiting |
| Institut de Cancérologie de Lorraine | Vandœuvre-lès-Nancy, France | Not Yet Recruiting |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05009927